Dr. Somlo on Novel Agents in Multiple Myeloma
George Somlo, MD
George Somlo, MD, medical oncologist, City of Hope, discusses some of the novel agents being evaluated for the treatment of patients with multiple myeloma.
Several new agents have been approved by the FDA in the past year, and oncologists are currently learning how to best utilize them, especially in combination with one another, explains Somlo.
The overall goal, says Somlo, is to both improve the toxicity profile of some of the older agents in this space, as well as bring the novel agents into the frontline setting.